
Figure 1: Flowchart displays the chemotherapy waiting process before the action plan implementation.
Chemotherapy |
Total time (Pre-Action Plan) |
Total time (Post-Action Plan) |
% Improvement post-change |
Velcade |
102.86 |
26.75 |
73.99 |
Herceptin |
97.65 |
26.26 |
73.10 |
Taxol |
96.50 |
44.60 |
53.78 |
Vedolizumab |
93.33 |
40.00 |
57.14 |
MTX |
89.00 |
29.32 |
67.06 |
Decitabine |
80.33 |
42.00 |
47.72 |
Natalizumab |
79.60 |
41.00 |
48.49 |
Infliximab |
74.74 |
41.00 |
45.14 |
Average Waiting Time |
89.25 |
36.37 |
59.25 |
Table 1: The average waiting time (since check-in until administering the treatment dose) for 8 different chemotherapy protocols before and after implementation of the action plan, by calculating the percentage of improvement
Figure 1: Flowchart displays the chemotherapy waiting process before the action plan implementation.
Figure 2: RCA diagram demonstrating the factors affecting the prolonged chemotherapy waiting time. (The star indicates the most contributing factor)
Figure 3: Bar graph demonstrates a reduction in waiting time for the 8 different chemotherapy protocols after the implementation of the action plan.
Figure 4: Run chart shows the improvement in patient satisfaction rate post-intervention.
Figure 5: A) Run chart showed the dramatic decrease in overtime, B) Horizontal Bar graph displays the percentage reduction of overtime post-action plan.
Tables at a glance
Figures at a glance